SOLX Gold Shunt for Refractory Glaucoma
What is the purpose of this trial?
To establish the clinical performance of the SOLX Gold Shunt for its ability to reduce intraocular pressure (IOP) in eyes with refractory glaucoma where medical and conventional surgical treatments have failed.
- 21 Years and older
- SOLX, Inc.
- January 2011
- Last Updated:
- July 9, 2012
- Study HIC#:
Clinicaltrials.gov ID: NCT01282346